PTT GLBL CHEM.-NVDR- BA10 (GCB1) - Total Liabilities
Based on the latest financial reports, PTT GLBL CHEM.-NVDR- BA10 (GCB1) has total liabilities worth €310.60 Billion EUR (≈ $363.13 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore GCB1 net asset momentum to track the company's year-over-year net asset growth rate.
PTT GLBL CHEM.-NVDR- BA10 - Total Liabilities Trend (2022–2025)
This chart illustrates how PTT GLBL CHEM.-NVDR- BA10's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of PTT GLBL CHEM.-NVDR- BA10 to measure how efficiently the company converts operating cash flow to free cash.
PTT GLBL CHEM.-NVDR- BA10 Competitors by Total Liabilities
The table below lists competitors of PTT GLBL CHEM.-NVDR- BA10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reinet Investments SCA
JSE:RNI
|
South Africa | ZAC-129.49 Billion |
|
Xinfengming Group Co Ltd
SHG:603225
|
China | CN¥46.00 Billion |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
USA | $651.99 Million |
|
BURBERRY GROUP ADR/
F:BB2A
|
Germany | €2.11 Billion |
|
Energy Fuels Inc
NYSE MKT:UUUU
|
USA | $731.35 Million |
|
Travel + Leisure Co
NYSE:TNL
|
USA | $7.86 Billion |
|
Zhejiang Shuanghuan Driveline Co Ltd
SHE:002472
|
China | CN¥8.27 Billion |
|
Akero Therapeutics Inc
NASDAQ:AKRO
|
USA | $47.94 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down PTT GLBL CHEM.-NVDR- BA10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PTT GLBL CHEM.-NVDR- BA10 market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PTT GLBL CHEM.-NVDR- BA10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PTT GLBL CHEM.-NVDR- BA10 (2022–2025)
The table below shows the annual total liabilities of PTT GLBL CHEM.-NVDR- BA10 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €310.60 Billion ≈ $363.13 Billion |
-17.67% |
| 2024-12-31 | €377.25 Billion ≈ $441.05 Billion |
-10.78% |
| 2023-12-31 | €422.82 Billion ≈ $494.33 Billion |
+0.40% |
| 2022-12-31 | €421.14 Billion ≈ $492.35 Billion |
-- |
About PTT GLBL CHEM.-NVDR- BA10
PTT Global Chemical Public Company Limited operates as a chemical company in Thailand and internationally. It operates through six segments: Upstream, Intermediates, Polymers and Chemicals, Bio and Circularity, Performance Chemicals, and Service and Others. The company offers chemical products, such as petroleum, olefins, aromatics, purified terephthalic acid (PTA), EO-based performance, phenol, … Read more